Wikiwand AI

AAVAnc80-hOTOF

From Wikipedia, the free encyclopedia

Experimental gene therapy for a form of hearing loss

AAVAnc80-hOTOF is an experimental gene therapy for otoferlin gene-mediated hearing loss.^[1]^[2]

↑ Jiang, Luoying; Wang, Daqi; He, Yingzi; Shu, Yilai (April 2023). "Advances in gene therapy hold promise for treating hereditary hearing loss". Molecular Therapy. 31 (4): 934–950. doi:10.1016/j.ymthe.2023.02.001. PMC 10124073. PMID 36755494.
↑ Hickox, Ann E.; Valero, Michelle D.; McLaughlin, James T.; Robinson, Gregory S.; Wellman, Jennifer A.; McKenna, Michael J.; Sewell, William F.; Simons, Emmanuel J. (November 2021). "Genetic Medicine for Hearing Loss: OTOF as Exemplar". Journal of the American Academy of Audiology. 32 (10): 646–653. doi:10.1055/s-0041-1730410. PMID 35609591.

Related Articles

Wikiwand AI

Wikiwand AI

👋

Company

Home
Upgrade
About
Contact

Product

Articles
Timelines
Top Questions
Fact Checks

Extensions

Chrome
Firefox
Edge

Social

X
Instagram
Facebook
LinkedIn

Sign in Site map Privacy Terms of use © 2026 Wikiwand. All rights reserved.